Earnings

Oppenheimer Holdings finds itself navigating conflicting currents as its latest financial results reveal a company caught between impressive revenue expansion...

Aclaris Therapeutics witnessed a significant selloff in its stock price after releasing disappointing third-quarter 2025 financial results. The biotechnology firm...

Investor attention is focused on BioAtla Inc following the release of compelling clinical trial results for its lead oncology asset,...

Protara Therapeutics, a clinical-stage biotechnology firm, delivered an impressive quarterly performance that has reignited market interest. The company not only...

The medical technology sector is witnessing a remarkable performance from Globus Medical, whose recent quarterly results have generated significant market...

FAT Brands Inc. finds itself in a precarious financial position as its shares hover near yearly lows. The restaurant franchisor's...

The medical technology firm TransMedics continues to post impressive operational results, yet its share price tells a conflicting story. Despite...

While investors reacted cautiously to mixed quarterly figures, a far more significant development is unfolding behind the scenes at Capital...

Euronet Worldwide finds itself navigating challenging market conditions as its stock price plunges to fresh 52-week lows. The financial services...

Amid market turbulence, Hercules Capital has positioned itself as a defensive play with an attractive dividend yield. However, a closer...